FDA Elevates Thyroid Pill Recall to Class I Due to Potency Concerns

Buzzline

The FDA has classified a nationwide recall of thyroid medications as Class I, its highest level of concern, following the discovery that the pills contain higher amounts of active ingredients than indicated on their labels. Vitruvias Therapeutics has proactively recalled the impacted batch of Thyroid Tablets, USP, which saw the distribution of 1,955 bottles across the nation prior to the identification of this risk. Class I recalls are reserved for instances where the use of the product poses a significant risk of serious health effects or death, prompting the agency to advise anyone using this specific batch to immediately verify their product and consult with their pharmacist or healthcare provider before taking any further doses. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.  ai-generated

Transcript

00:00The FDA just issued its most serious possible warning on a common thyroid medication,

00:05and patients need to check their bottles right now.

00:07Regulators elevated this nationwide recall to Class 1, the FDA's highest risk classification.

00:14After discovering the pills were super potent,

00:17meaning they contain more active ingredient than the label actually states,

00:21Vitruvius Therapeutics voluntarily recalled the affected lot of thyroid tablets.

00:25With 1955 bottles already distributed to pharmacies across the country,

00:30before anyone caught the danger.

00:31The FDA reserves this top classification specifically for situations

00:36where using the product could cause serious adverse health consequences or even death.

00:41Health officials are urging anyone currently taking this medication

00:44to check their bottle's lot number immediately against the recall notice.

00:49Patients are being told to contact their pharmacist or doctor right away

00:53before taking another dose from the affected supply.

00:56Disclosure.

00:57This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

Transcript

Comments

Recommended